103 related articles for article (PubMed ID: 10915749)
1. The significance of baseline serum alanine aminotransferase on pretreatment disease characteristics and response to antiviral therapy in chronic hepatitis C.
Gordon SC; Fang JW; Silverman AL; McHutchison JG; Albrecht JK
Hepatology; 2000 Aug; 32(2):400-4. PubMed ID: 10915749
[TBL] [Abstract][Full Text] [Related]
2. Association of response to combined interferon alpha-2b and ribavirin therapy in patients of chronic hepatitis c with serum alanine aminotransferase levels and severity of the disease on liver biopsy.
Nadeem A; Hussain MM; Aslam M; Hussain T; Butt IF; Ali Khan S; Asad A
J Ayub Med Coll Abbottabad; 2009; 21(2):103-6. PubMed ID: 20524482
[TBL] [Abstract][Full Text] [Related]
3. Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group.
Davis GL; Esteban-Mur R; Rustgi V; Hoefs J; Gordon SC; Trepo C; Shiffman ML; Zeuzem S; Craxi A; Ling MH; Albrecht J
N Engl J Med; 1998 Nov; 339(21):1493-9. PubMed ID: 9819447
[TBL] [Abstract][Full Text] [Related]
4. Viral kinetics during antiviral therapy in patients with chronic hepatitis C and persistently normal ALT levels.
Kronenberger B; Herrmann E; Micol F; von Wagner M; Zeuzem S
Hepatology; 2004 Dec; 40(6):1442-9. PubMed ID: 15565603
[TBL] [Abstract][Full Text] [Related]
5. Discordance between serum alanine aminotransferase (ALT) and virologic response to IFN-alpha2b in chronic hepatitis C patients with high and low pretreatment serum hepatitis C virus RNA titers.
Blatt LM; Tong MJ; McHutchison JG; Russell J; Schmid P; Conrad A
J Interferon Cytokine Res; 1998 Feb; 18(2):75-80. PubMed ID: 9506457
[TBL] [Abstract][Full Text] [Related]
6. Serum alanine aminotransferase level and response to interferon-ribavirin combination therapy in patients with chronic hepatitis C.
Sarwar S; Butt AK; Khan AA; Alam A; Ahmad I; Dilshad A
J Coll Physicians Surg Pak; 2006 Jul; 16(7):460-3. PubMed ID: 16827956
[TBL] [Abstract][Full Text] [Related]
7. Lymphoblastoid interferon alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alfa-2b: results of an international randomized controlled trial. Clinical Advisory Group for the Hepatitis C Comparative Study.
Farrell GC; Bacon BR; Goldin RD
Hepatology; 1998 Apr; 27(4):1121-7. PubMed ID: 9537453
[TBL] [Abstract][Full Text] [Related]
8. [Therapy with interferon alfa and ribavirin in patients with chronic hepatitis C and normal levels of alanine aminotransferase].
Duvnjak M; Pavić T; Virović L; Hrabar D
Acta Med Croatica; 2003; 57(3):159-62. PubMed ID: 14582461
[TBL] [Abstract][Full Text] [Related]
9. Alanine aminotransferase (ALT) levels in a normal population and interferon therapy in chronic hepatitis C patients with normal ALT.
Sakugawa H; Nakasone H; Nakayoshi T; Kawakami Y; Yamashiro T; Maeshiro T; Kinjo F; Saito A; Yakabi S
Hepatogastroenterology; 2003; 50(49):165-9. PubMed ID: 12630015
[TBL] [Abstract][Full Text] [Related]
10. Maintenance therapy with ribavirin in patients with chronic hepatitis C who fail to respond to combination therapy with interferon alfa and ribavirin.
Hoofnagle JH; Ghany MG; Kleiner DE; Doo E; Heller T; Promrat K; Ong J; Khokhar F; Soza A; Herion D; Park Y; Everhart JE; Liang TJ
Hepatology; 2003 Jul; 38(1):66-74. PubMed ID: 12829988
[TBL] [Abstract][Full Text] [Related]
11. IFN-alpha2b monotherapy in patients with chronic hepatitis C and persistently normal or near normal aminotransferase activity: a randomized, controlled study.
Tassopoulos NC; Vafiadis I; Tsantoulas D; Syrokosta J; Hatzis G; Delladetsima JK; Demonakou M; Sypsa V; Hatzakis AE
J Interferon Cytokine Res; 2002 Mar; 22(3):365-9. PubMed ID: 12034044
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of interferon alpha and ribavirin treatment for chronic hepatitis C in patients with normal serum aminotransaminases.
Hui CK; Monto A; Belaye T; Lau E; Wright TL
Gut; 2003 Nov; 52(11):1644-8. PubMed ID: 14570736
[TBL] [Abstract][Full Text] [Related]
13. Hepatic HCV RNA before and after treatment with interferon alone or combined with ribavirin.
McHutchison JG; Poynard T; Esteban-Mur R; Davis GL; Goodman ZD; Harvey J; Ling MH; Garaud JJ; Albrecht JK; Patel K; Dienstag JL; Morgan T;
Hepatology; 2002 Mar; 35(3):688-93. PubMed ID: 11870385
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of interferon treatment for patients with chronic hepatitis C: comparison of response in cirrhotics, fibrotics, or nonfibrotics.
Everson GT; Jensen DM; Craig JR; van Leeuwen DJ; Bain VG; Ehrinpreis MN; Albert D; Joh T; Witt K
Hepatology; 1999 Jul; 30(1):271-6. PubMed ID: 10385666
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of entecavir in chronic hepatitis B patients with mildly elevated alanine aminotransferase and biopsy-proven histological damage.
Wu IC; Lai CL; Han SH; Han KH; Gordon SC; Chao YC; Tan CK; Sievert W; Tanwandee T; Xu D; Neo BL; Chang TT
Hepatology; 2010 Apr; 51(4):1185-9. PubMed ID: 20044806
[TBL] [Abstract][Full Text] [Related]
16. Sequential versus concomitant administration of ribavirin and interferon alfa-n3 in patients with chronic hepatitis C not responding to interferon alone: results of a randomized, controlled trial.
Sostegni R; Ghisetti V; Pittaluga F; Marchiaro G; Rocca G; Borghesio E; Rizzetto M; Saracco G
Hepatology; 1998 Aug; 28(2):341-6. PubMed ID: 9695995
[TBL] [Abstract][Full Text] [Related]
17. [Efficacy of combination therapy with interferon-alpha and ribavirin for chronic hepatitis C in relation to liver fibrosis and serum aminotransferase activity].
Karpińska E; Wawrzynowicz-Syczewska M; Jurczyk K; Morańska I; Urbanowicz W; Boroń-Kaczmarska A
Wiad Lek; 2005; 58(11-12):616-21. PubMed ID: 16594470
[TBL] [Abstract][Full Text] [Related]
18. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group.
McHutchison JG; Gordon SC; Schiff ER; Shiffman ML; Lee WM; Rustgi VK; Goodman ZD; Ling MH; Cort S; Albrecht JK
N Engl J Med; 1998 Nov; 339(21):1485-92. PubMed ID: 9819446
[TBL] [Abstract][Full Text] [Related]
19. Characteristics and outcomes of HCV genotype-1-infected patients treated with peginterferon and ribavirin combination therapy with discordant HCV responses 4 and 12 weeks after starting therapy.
Toyoda H; Kumada T; Shimada N; Takaguchi K; Ide T; Sata M; Ginba H; Matsuyama K; Izumi N
Intervirology; 2014; 57(5):289-96. PubMed ID: 24992890
[TBL] [Abstract][Full Text] [Related]
20. Combination therapy with thymosin alpha1 and interferon for the treatment of chronic hepatitis C infection: a randomized, placebo-controlled double-blind trial.
Sherman KE; Sjogren M; Creager RL; Damiano MA; Freeman S; Lewey S; Davis D; Root S; Weber FL; Ishak KG; Goodman ZD
Hepatology; 1998 Apr; 27(4):1128-35. PubMed ID: 9537454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
